Systemic Half-Life: The systemic half-life of injectable BPC-157 is relatively short, estimated to be between 4 and 6 hours
Again, these effects can be explained on the basis of its ability to produce telomerase and decrease free radicals
All products are intended strictly for research purposes only and not for human consumption
It plays a role in supporting the bodys immune response by helping maintain a balanced and effective immune system
(1) This peptide appears to be naturally present in the bloodstream and has been suggested as a potential element in regulating the growth, development, and apoptosis of vascular endothelial cells
Important Notes These are the points most often dropped when AHK-Cu is marketed as an injectable hair-growth peptide. No human trial exists state it plainly: there is no clinical trial of AHK-Cu by any route, and the entire peptide-specific peer-reviewed base is one 2007 study that was ex vivo and in vitro [1]